MIG7 Blocking Peptide for STJ501755 peptide (STJ504370)

SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 170-220 on MIG7 protein.
STJ504370-250
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionMIG7 Blocking Peptide for STJ501755 is synthetically produced from the 170-220 sequence and is suitable for use in western blot applications.
ApplicationsImmunodepletion/Immunocompetition
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

FormulationLiquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage InstructionStore at-20ยฐC for long term storage. Avoid freeze-thaw cycles.

Target Information

ImmunogenSynthetic peptide taken within amino acid region 170-220 on MIG7 protein.
Immunogen Region170-220
SpecificityThis blocking peptide is recommended for use in combination with MIG7 antibody, STJ501755

Citations

Product Review